3Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by Interferon-gamma.J Immunol 1986; 136:2445-2450.
4Niitsuma H, Ishii M, Miura M, Toyota T. Detection of HBV precore mutation by PCR-RFLP. Nippon Rinsho 1995; 53 Suppl(Pt 2): 316-320.
5Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatoceUular carcinoma. J Gastroenterol Hepatol 2000; 15(Suppl):E25-30.
6Bertoletti A, Sette A, Chisari FV, Penna A, Giuberti T, Levrero M, De Carli M, Fiaccadori F, Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369:407-410.
7Ohta A, Sekimoto M, Sato M, Koda T, Nishimura S, Iwakura Y,Sekikawa K, Nishimura T. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen. J Immunol 2000;165:956-961.
8Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL,Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; 2:72-74.
9Tanaka Y, Takahashi A, Watanabe K, Takayama K, Yahata T,Habu T, Nishimura T. A pivotal role of IL-12 in Thl-dependent mouse liver iniury. Int Immunol 1996; 8:569-576.
10Lehmann V, 16reudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and Dgalactosamine-treated mice. J Exp Med 1987: 165:657-663.
